EUVIMED · CrossrefJournal
Journal of Immunotherapy and Precision Oncology
ISSN 2590-017X · Innovative Healthcare Institute
Latest articles
Impact of Concomitant Medication Use on Treatment Outcomes in Patients with Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
Releasing Immunosuppression in the Tumor: A Phase 1/2 Study of Arginase Inhibitor INCB001158 in Combination with Chemotherapy in Advanced Malignancies
Outcomes of Patients with Rare Cancers Treated with Immune Checkpoint Inhibitors with and Without Lung and/or Liver Metastases (NCI/SWOG S1609)
Molecular Archeology of Cancer: Unearthing Precision Multiomic Drivers for N-of-1 Therapeutics
State of Precision Oncology: An Australian Perspective
Molecular Profiling in Asia: The Current Status and Approach
Molecular Profiling and Precision Oncology for Non–Small Cell Lung Cancer in Latin America: Unique Epidemiology, Persistent Barriers, and Paths Toward Equity
Clinical, Radiologic, and Highest-Grade Assessment of Immune Checkpoint Inhibitor Pneumonitis in Non–Small Cell Lung Cancer
Evidence for Dose Optimization of Immune Checkpoint Inhibitors
Moving Beyond the Plateau in Immune Checkpoint Inhibition—The Imperative of Early Referral and Precision Strategies
Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors
The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
From Promise to Precision: The Next Chapter of Checkpoint Inhibition
A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors
Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study
Colonic Polyp Regression After Nous-209 Cancer Immunotherapy: A Clinical Trial Case Report
ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6
Impact of Germline BRCA Status on Pathologic Complete Response (pCR) and Outcomes in Early TNBC Treated with Pembrolizumab-Based Neoadjuvant Chemotherapy (KEYNOTE-522 Regimen): A Real-World Study
Navigating Complexity in the Precision Oncology Clinic: Pharmacists’ Central Role in Drug Selection, Acquisition, and Dosing in a Real-World Clinic
Beyond Visibility: Social Media, Trust, and Responsibility in Oncology
Bispecific Antibodies in Solid Tumors: Mechanistic Insights, Clinical Advances, and Future Directions
SMARCA4-Directed Treatment in Oncology Clinical Trials: A Review
Emerging Therapeutic Strategies in Metastatic Hormone-Sensitive Prostate Cancer
Abstracts Presented at the 2026 Precision Oncology Saudi Summit: February 12–14, 2026, Madinah, Saudi Arabia
Abstracts for the 2026 Immunotherapy and Precision Oncology Forum: April 11, 2026, Cincinnati, OH, USA
Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
Exceptional Response to Immunotherapy-based Treatment in Compound EGFR-Mutated Oligometastatic Pulmonary Sarcomatoid Carcinoma: A Case Report
B7 Homolog 4 (B7-H4)-Directed Agents in Oncology Clinical Trials: A Review
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions
EUVIMED